Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2019 | 11-2018 | 11-2017 | 12-2016 | 11-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2 | N/A | N/A | N/A | N/A |
| Income taxes - deferred | -3 | -27 | -40 | N/A | -5 |
| Accounts receivable | -17 | 64 | -19 | -12 | -14 |
| Accounts payable and accrued liabilities | 147 | 20 | N/A | N/A | N/A |
| Other Working Capital | -90 | 81 | 32 | 17 | 220 |
| Other Operating Activity | -677 | -628 | -597 | -40 | -368 |
| Operating Cash Flow | $-638 | $-490 | $-624 | $-35 | $-169 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | N/A | -533 | N/A | -164 |
| Net Acquisitions | N/A | 0 | 54 | N/A | 0 |
| Other Investing Activity | -168 | -224 | 287 | 0 | 163 |
| Investing Cash Flow | $-170 | $-224 | $-192 | $N/A | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 31 | 40 | N/A | N/A | N/A |
| Debt Repayment | -9 | -8 | -5 | N/A | 0 |
| Common Stock Issued | 793 | 910 | 737 | 643 | 122 |
| Other Financing Activity | -80 | -97 | 99 | 0 | -2 |
| Financing Cash Flow | $736 | $844 | $832 | $643 | $120 |
| Beginning Cash Position | 147 | 17 | 2 | 89 | 51 |
| End Cash Position | 76 | 147 | 17 | 697 | 2 |
| Net Cash Flow | $-71 | $130 | $15 | $608 | $-49 |
| Free Cash Flow | |||||
| Operating Cash Flow | -638 | -490 | -624 | -35 | -169 |
| Capital Expenditure | -2 | N/A | -533 | N/A | -164 |
| Free Cash Flow | -640 | -490 | -1,157 | -35 | -332 |